Drug search by name
Panitumumab Intravenous and Spravato (84 MG Dose)
Determining the interaction of Panitumumab Intravenous and Spravato (84 MG Dose) and the possibility of their joint administration.
Check result:
Panitumumab Intravenous <> Spravato (84 MG Dose)
Relevance: 06.07.2022
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Panitumumab Intravenous
Generic Name: panitumumab
Brand name: Vectibix
Synonyms: Panitumumab
Spravato (84 MG Dose)
Generic Name: esketamine
Brand name: Spravato
Synonyms: Spravato Nasal Spray, Spravato
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Panitumumab Intravenous-Sprintec
- Panitumumab Intravenous-Sprintec 28
- Panitumumab Intravenous-Spritam
- Panitumumab Intravenous-Sprix
- Panitumumab Intravenous-Sprix Nasal Spray
- Panitumumab Intravenous-Sprycel
- Spravato (84 MG Dose)-Panixine
- Spravato (84 MG Dose)-Panixine DisperDose
- Spravato (84 MG Dose)-Panlor
- Spravato (84 MG Dose)-Panlor Tablet
- Spravato (84 MG Dose)-Panlor Tablets
- Spravato (84 MG Dose)-Panlor-DC
Doktika World
Interaction with food and lifestyle
Disease interaction